Stefano Cainelli

Stefano Cainelli has extensive work experience in the finance sector. Stefano currently serves as the Vice President of Finance Operations at MorphoSys, starting in August 2022. Before this, they worked at Sarepta Therapeutics as the Executive Director Head of Finance EMEA from August 2020 to August 2022, and as the Senior Director Head of Finance Europe from July 2018 to July 2020. Prior to that, Stefano held various roles at Gilead Sciences, including Director Finance & Distribution Switzerland from May 2013 to June 2018, Associate Director Financial Planning & Analysis EMEA Region from July 2011 to April 2013, Head of Finance Partner Markets in Asia, Europe, Latin America and Middle East from July 2009 to June 2011, and Senior Manager Financial Planning International Operations from September 2006 to June 2009. Stefano also worked at AstraZeneca Italia Spa as a Financial Controller from January 2005 to August 2006, and at Eli Lilly and Company in roles such as Senior Manager Financial Planning from September 2002 to January 2005, Head of Finance Switzerland from October 2000 to September 2002, and Financial Analyst from January 1999 to September 2000. Stefano began their career as a Senior Auditor at KPMG Italy from January 1995 to August 1997.

Stefano Cainelli holds an MBA in General Management from SDA Bocconi. Prior to their MBA, they completed a Bachelor of Business Administration (BBA) in Business Administration and Management, General from Università Cattolica del Sacro Cuore. The exact duration of their studies at both institutions is not provided.